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During the assembly of the musculoskeletal system,
bone ridges provide a stable anchoring point and
stress dissipation for the attachment of muscles via
tendons to the skeleton. In this study, we investigate
the development of the deltoid tuberosity as a model
for bone ridge formation. We show that the deltoid
tuberosity develops through endochondral ossifica-
tion in a two-phase process: initiation is regulated
by a signal from the tendons, whereas the subse-
quent growth phase is muscle dependent. We then
show that the transcription factor scleraxis (SCX)
regulates Bmp4 in tendon cells at their insertion
site. The inhibition of deltoid tuberosity formation
and several other bone ridges in embryos in which
Bmp4 expression was blocked specifically in Scx-
expressing cells implicates BMP4 as a key mediator
of tendon effects on bone ridge formation. This study
establishes a mechanistic basis for tendon-skeleton
regulatory interactions during musculoskeletal
assembly and bone secondary patterning.
INTRODUCTION
The musculoskeletal system has played a pivotal role in the
evolutionary success of vertebrates by providing their bodies
with form, stability, and mobility. The proper functionality of the
musculoskeleton relies on precise assemblage and tight coordi-
nation among its components: skeletal tissue (bone, cartilage,
and joints), muscles, and tendons. The research of the muscu-
loskeleton as an integrated system has been scarce. As a result,
little is known about the regulatory interactions among its three
components during its development.
The appendicular skeleton forms by endochondral ossifica-
tion. During this process, cartilaginous templates are replaced
by bone and bonemarrow. The replacement of cartilage by ossi-
fied bone and its longitudinal growth are regulated by the growthDevelopmeplate. It is located near the ends of long bones and composed
of chondrocytes that undergo a well-defined and highly
controlled differentiation program (Karsenty and Wagner, 2002;
Olsen et al., 2000).
Several signaling pathways are known to regulate chondro-
cyte differentiation, notably bone morphogenetic proteins
(BMPs), members of the transforming growth factor b (TGF b)
superfamily (Pogue and Lyons, 2006). BMP ligands bind to
their specific serine/threonine kinase receptor and initiate a
signaling cascade leading to the phosphorylation of transcription
regulators, the Smad proteins (Smad 1/5/8). The P-Smad
1/5/8 then translocate into the nucleus and activate the tran-
scription of various target genes (Massague et al., 2005). The
ability of BMPs to induce ectopic cartilage suggests an involve-
ment of these factors in chondrogenesis (Reddi and Huggins,
1972; Urist, 1965; Wozney et al., 1988). Indeed, abrogation of
the expression of both BMP type 1 receptors, Bmpr1a and
Bmpr1b, in chondrocytes has demonstrated the role of BMPs
in chondrocyte proliferation, survival, and differentiation (Yoon
et al., 2005).
While the longitudinal growth of bone has attractedmost of the
attention, a secondary patterning process also exists. Different
bones grow protrusions of varying shapes and sizes on their
surface, structures that are significant in the final and specific
design of each bone. Bone protrusions are divided into two
groups: articular and nonarticular. Examples of articular
eminences are found in the heads of the humerus and femur.
Nonarticular eminences are located along the bone shaft and
termed according to their form. Thus, a rough elevation that
stretches along the surface is termed a ridge or crest, whereas
a broad, rough, irregular ridge is called a tuberosity.
Bone ridges play a fundamental role in the functionality of
the musculoskeletal system, providing a stable anchoring point
for muscles, inserted to the skeleton via tendons. Most of the
mechanical load applied to the skeleton, generated by muscle
contraction and transduced by tendons, encounters bone ridges
first. These structures then absorb and dissipate some of the
stress concentrated at the hard-soft tissue interface, thereby
diminishing the risk of avulsion fractures (Biewener et al., 1996;
Benjamin et al., 2002).ntal Cell 17, 861–873, December 15, 2009 ª2009 Elsevier Inc. 861
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mechanisms that regulate bone ridge patterning and develop-
ment are mostly unknown. Notwithstanding, several studies
performed in different systems including bone transplantation,
immobilized chick embryos, and mice that lack functional
musculature (Hamburger, 1938, 1939, 1940; Hall and Herring,
1990; Hosseini and Hogg, 1991; Pai, 1965a; Rot-Nikcevic et al.,
2006; Tremblay et al., 1998) have suggested the contribution of
mechanical load created by muscle contraction to the formation
of bone ridges. In the limb, muscle progenitors develop in close
proximity to tendon precursors and the morphogenesis of these
two tissues is tightly coupled, both spatially and temporally
(Kardon, 1998; Schweitzer et al., 2001). Surgical manipulations
in chick embryos and genetic analyses in mice have shown that
limb tendon development can be initiated in the absence of
muscles; however, later in development, tendon maintenance
requires the presence of muscles (Bonnin et al., 2005; Brent
et al., 2005; Edom-Vovard et al., 2002; Kardon, 1998; Kieny and
Chevallier, 1979; Schweitzer et al., 2001).
Unlike the musculature and the skeleton, the molecular
aspects of tendon development have only recently begun to be
uncovered. The finding that scleraxis (SCX), a bHLH transcrip-
tion factor, is expressed in progenitors and cells of all tendinous
tissues and regulates their differentiation (Cserjesi et al., 1995;
Murchison et al., 2007; Schweitzer et al., 2001) provides amolec-
ular entry point into tendon development. Despite these
advances, little is known about the interaction between tendon
and cartilage cells in the forming limb.
As a model for studying the regulatory role of interactions
among different tissues during musculoskeletal assembly, we
investigated the development of a bone ridge named the deltoid
tuberosity (referred to hereafter as DT). We show a temporally
regulated and coordinated contribution of both tendons and
muscles to DT development, as tendons regulate tuberosity
initiation and muscles control its growth. We then describe
a molecular pathway that mediates a crosstalk between carti-
lage and tendons whereby BMP4, produced by tendon cells at
the insertion site under the regulation of SCX, regulates bone
ridge formation.
RESULTS
DT Develops through Endochondral Bone Formation
Very little is known about the formation of bone ridges. As
a model for studying the development of these structures we
chose the DT, a bone ridge located on the shaft of the humerus
that exhibits a well-defined morphology.
To document DT development, we stained skeletons of
E14.5–E18.5 wild-type (WT) embryos with Alizarin red and Alcian
blue. At E14.5, we observed the emergence of the tuberosity
from the lateral aspect of the proximal third of the humerus
(Figure 1A). As DT development proceeded, it maintained its
growth; concomitantly, it underwent ossification, except for
a cartilaginous part at its tip (Figures 1B and 1C).
To study the cellular mechanism by which the DT forms, we
next analyzed histologically sagittal and transverse sections of
E13.5–E18.5 WT limbs. At E13.5, a group of cells with a distinc-
tive appearance emerge from the proximal epiphysis of the
humerus, indicating the initiation of DT formation (Figure 1D).862 Developmental Cell 17, 861–873, December 15, 2009 ª2009 ElsAt E14.5, these cells appeared similar to chondrocytes in the
proliferative zone of the humerus primary growth plate (Figures
1E and 1H). At later stages (E16.5), we observed prehypertrophic
and hypertrophic chondrocytes (Figures 1F and 1I). Their emer-
gence was followed by blood vessel invasion and by E18.5
(Figures 1G and 1J) bone formation was clearly observed. This
sequence of events suggests that the DT develops through
endochondral ossification.
The hallmark of endochondral ossification is the formation of
a growth plate. To validate our hypothesis that the tuberosity is
formed by endochondral ossification, we examined the expres-
sion of growth plate markers in E16.5 WT embryos (Figures
1K–1O). The markers we analyzed included collagen type II
alpha 1 (Col2a1), a marker for resting and proliferating chondro-
cytes, Indian hedgehog (Ihh) and parathyroid hormone-related
peptide receptor (PTHrPR), markers for prehypertrophic chon-
drocytes, and collagen type X alpha 1 (Col10a1), a marker for
hypertrophic chondrocytes (Kronenberg, 2003). The differential
expression of theses markers in the developing DT (Figurse
1L–1O) strongly supports our conclusion that the tuberosity
develops by endochondral ossification.
To determine the growth direction of the tuberosity growth
plate, we examined cell proliferation by analyzing BrdU incorpo-
ration into cells of the DT. In E16.5 WT embryos, we detected
a group of proliferating chondrocytes at the tip of the DT (Fig-
ure 1P). This result indicates that the direction of DT growth is
different from that of the humerus primary growth plate.
Tuberosity Initiation Is Muscle Independent
Studies performed over the last century have established the
contribution of mechanical load created by muscle contraction
in the formation of bone ridges (Hamburger, 1938, 1939, 1940;
Hall andHerring, 1990;Hosseini andHogg,1991;Pai, 1965a;Rot-
Nikcevic et al., 2006; Tremblay et al., 1998). However, all those
studies document bone ridge development in ossified bones at
relatively advanced stages of skeleton development. Our finding
that the DT emerges as a cartilaginous template at an earlier
stage of skeletogenesis prompted us to study the role of the
musculature in regulating the initial stages of DT development.
We examined the skeletons of two strains of mutant mice with
muscular defects. The splotch delayedmutant (Spd) mice harbor
a naturally occurring point mutation in the Pax3 gene. Homozy-
gous Spd embryos lack all limb musculature due to a defect in
the migration of muscle progenitor cells to the developing limb
(Dickie, 1964; Franz et al., 1993). The second mouse strain,
which carries the naturally occurring autosomal recessive muta-
tion muscular dysgenesis (mdg), lacks excitation-contraction
coupling, leading to the absence of skeletal muscle contractility
(Pai, 1965a, 1965b).
First, we analyzed skeletal preparations of forelimbs from
E18.5 homozygous Spd and mdg embryos. Consistently with
previous findings, these skeletons lacked the DT (Figures 2A
and 2B) (Pai, 1965a; Rot-Nikcevic et al., 2006; Tremblay et al.,
1998).While bone ridge development was dramatically impaired,
a mild effect on the humerus longitudinal growth and ossification
was also observed at E18.5 (data not shown).
To determine the influence of the musculature on tuberosity
initiation, we examined embryonic skeletons at E14.5, 1 day after
DT development initiates. Surprisingly, the DT was present inevier Inc.
Figure 1. Developmental Analysis of the DT
(A–P) Black arrows indicate DT.
(A–C) Skeletal preparations of E14.5, E16.5, and E18.5 WT embryos (the boxed areas of the DT are enlarged on the left).
(D–J) Histological sagittal (D–G) and transverse (H–J) sections through the DT of E13.5–E18.5 WT mice (dotted circles indicate DT area).
(K–O) Tuberosity cell differentiation is demonstrated by the expression of growth plate markers.
(K) Histological sagittal section through the DT of E16.5 WT mice.
(L–O) In situ hybridization analysis of DT sagittal sections from E16.5 WT mice, using anti-sense complementary RNA probes for collagen II (Col II), Indian
hedgehog (Ihh), parathyroid hormone-related peptide receptor (PTHrPR), and collagen X (Col X) mRNA.
(P) BrdU incorporation in E16.5 WT mice; dotted circles indicate tuberosity tip.
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tionally, chondrocytes in the DT of the mdg mutant mice
continued their differentiation to hypertrophy (Figures 2E–2I);
however, they failed to maintain normal proliferation rate (see
Figure S2 available online).
These results demonstrate that DT development is a biphasic
process, consisting of initiation and growth phases. The initiation
phase is muscle-independent, whereas the subsequent growth
phase depends on muscle contraction.
Tendons Are Necessary for Bone Ridge Formation
Intrigued by the biphasic nature of DT development, we sought
to identify the trigger of the initiation phase. Recent reportsDevelopmehave demonstrated the lack of DT in embryos where the
expression of Tgf-b receptor II (Tgf-bRII) was conditionally tar-
geted in limb mesenchyme, using the Prx1-Cre as a deleter
mouse (Prx1-Tgf-bRII) (Seo and Serra, 2007; Spagnoli et al.,
2007; Baffi et al., 2004; Logan et al., 2002). Recently, we showed
that TGF-b signaling was essential for tendon development, as in
the Prx1-Tgf-bRII embryos tendons and ligaments were lost
(Pryce et al., 2009). In light of this evidence and given the
biphasic nature of tuberosity formation, we decided to use the
Prx1-Tgf-bRII embryos to study the role of tendon cells in DT
initiation.
First, to verify the loss of tendons at the attachment site
we examined the expression of scleraxis (SCX), a marker forntal Cell 17, 861–873, December 15, 2009 ª2009 Elsevier Inc. 863
Figure 2. Bone Ridge Development Is Disrupted in Mice with Defective Musculature
(A–D) Forelimbs of E18.5 (A and B) and E14.5 (C and D) control, Spd/Spd, andmdg/mdgmice stained with Alcian blue and Alizarin red. Black arrows indicate DT.
(E–I) Expression of growth plate markers in paralyzed embryos (dotted circles indicate DT area).
(E) Histological transverse sections of control and mdg mutant E16.5 tuberosity.
(F–I) In situ hybridization analysis of DT transverse sections from E16.5 control andmdgmice using anti-sense complementary RNA probes for collagen II (Col II),
Indian hedgehog (Ihh), parathyroid hormone-related peptide receptor (PTHrPR), and collagen X (Col X) mRNA.
Developmental Cell
Tendon Involvement in Bone Ridge Formationtendons, in embryos homozygous for floxed-Tgf-bRII and
heterozygous for Prx1-Cre alleles (Prx1-Tgf-bRII) and embryos
heterozygous for floxed-Tgf-bRII and Prx1-Cre alleles (control).
As expected, no Scx expression could be observed in Prx1-
Tgf-bRII forelimbs (Figures 3A and 3B). Next, we studied DT initi-
ation in the Tgf-bRII-ablated limbs. Skeletal preparations of
E14.5 Prx1-Tgf-bRII forelimbs lacked DT initiation (Figure 3C).
These results strongly imply that tendons are necessary for the
initial signal that induces the formation of the DT.
SCX Is Necessary for DT Initiation
Our finding that tendons are necessary for DT initiation prompted
us to screen for molecules that mediate this interaction. We
previously showed that Scx/ newborn mice lacked the tuber-
osity and suggested that the phenotype might be attributed to
a failure in the transmission of mechanical load from muscles864 Developmental Cell 17, 861–873, December 15, 2009 ª2009 Elsto the skeleton, due to tendon abnormality (Murchison et al.,
2007). Having found an involvement of tendons in the induction
of DT formation, we postulated that SCX might regulate tuber-
osity initiation. SCX is essential for tendon differentiation and
in Scx/ mice—some of the tendons appeared rudimentary
and others were completely missing (Murchison et al., 2007).
Therefore, we first had to verify that tendons formed at the
Scx/ humerus attachment site, prior to DT initiation. To this
end, we crossed the ScxGFP transgenic tendon reporter mouse
into the Scx/ background (Pryce et al., 2007). In sagittal
sections through the humeri of E13.5 embryos, tendons attach-
ing at the initiation site of the DT, visualized as ScxGFP-positive
cells, were observed in both Scx+/ (control) and Scx/mutants
(Figure 3D). Thus, despite the presence of tendon cells at the
humerus insertion site of Scx/ mutant embryos, these
embryos lacked DT initiation (Figures 3E and 3F).evier Inc.
Figure 3. Tendons Regulate DT Initiation through Scleraxis
(A–J) Black arrows point at DT.
(A and B) Detection of scleraxis expression as an indication for tendon formation in Prx1-Tgf-bRII embryos.
(A) Histological sagittal sections through the humeri of control and Prx1-Tgf-bRII mice.
(B) In situ hybridization of sections through the humeri of control and Prx1-Tgf-bRII embryos at E14.5, using Scx probe.
(C) Skeleton preparation of control and Prx1-Tgf-bRII mice.
(D) Sagittal sections through the humeri of control and Scx/ embryos carrying the ScxGFP reporter and counterstained with anti-collagen II antibody. White
arrows mark tendon attachment site and the presumable initiation site of the DT (green, tendon; red, cartilage).
(E and F) Detection of DT by (E) histological sagittal sections through the humerus and (F) skeleton preparation of E14.5 Scx/ mutant.
(G–J) Scx expression in control, muscle-less (homozygous Spd), and paralyzed (mdg) mice.
(G and I) Histological sagittal sections through the humeri of control, Spd, and mdg mutant mice.
(H and J) In situ hybridization through the humeri of control and Spd and mdg embryos at E14.5, using Scx probe.
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Spd and mdg mutant mice, which display normal initiation. As
expected, Scxwas expressed at the initiation site in both strains,
similarly to control mice (Figures 3G–3J). These results implicate
SCX as a key molecule in the regulation of DT initiation by
tendons.
Bmp4 Expression in Tendons Is Regulated by SCX
The regulation of DT initiation by SCX must operate through
a cell-nonautonomous mechanism, since Scx expression is
restricted to tendons. Because SCX is a transcription factor,
we performed a miniscreen of candidate molecules to identify
secreted factors that act downstream to SCX and mediate
the nonautonomous initiation signal from the tendons to the
skeleton. We detected bone morphogenetic protein 4 (Bmp4)
expression in tendon cells at the attachment site at E13.5,
making it a likely candidate to initiate tuberosity formation
(Figures 4A–4C). Moreover, Bmp4 expression in tendons was
colocalized with Scx expression, mainly at the attachment siteDevelopme(Figures 4A and 4C). The coexpression of Bmp4 and Scx was
also observed in other tendon-cartilage intersections, such as
the elbow joint (Figure 4B).
The coexpression of Scx and Bmp4 in tendon-cartilage inter-
sections prompted us to examine whether SCX is necessary for
Bmp4 expression in tendons. The specific loss of Bmp4 expres-
sion at the tendon insertion site of Scx/ embryos implied that
SCX acts upstream to BMP4 in tendon cells (Figures 4C and 4D).
SCX Regulates the Transcription of Bmp4
The coexpression of Scx and Bmp4 and the reduction in Bmp4
expression in tendon-cartilage intersection point of Scx/
mice led us to determine whether or not SCX regulates the
transcription of Bmp4. First, we examined the ability of Scx
overexpression to induce an increment in Bmp4 expression in
cell culture, by either transiently or stably transfecting Scx into
C3H10T1/2 cells. In both cases, quantitative RT-PCR revealed
an elevation in Bmp4 expression in Scx-transfected cells
(Figures 4E and 4F). To determine whether or not the increasedntal Cell 17, 861–873, December 15, 2009 ª2009 Elsevier Inc. 865
Figure 4. BMP4 Acts Downstream of Scleraxis
(A) Double fluorescent in situ hybridization of DT sagittal sections from E13.5 WT mice, using anti-sense complementary RNA probes for Scx and Bmp4; white
arrows mark tendon insertion site.
(B) In situ hybridization of forelimb joint sagittal sections from E14.5 WT mice, using anti-sense complementary RNA probes for Scx and Bmp4.
(C and D) In situ hybridization analysis of sagittal sections of humeri at E13.5, using anti-sense complementary RNA probes for Scx andBmp4; black arrowsmark
tendon insertion site.
(E and F) qRT-PCR analysis ofBmp4mRNA levels in C3T1/2H10 cells transiently (E) or stably (F) transfected with Scx. Stable cells (F) were transfected with empty
vector or Scx and passed selection or kept in culture without transfection (n/t).
(G) Luciferase activity in HeLa cells transfected with indicated plasmids: PGL3 B4 full, 750–+100 promoter region; B4 mut, promoter region with E-boxes
mutated; del1 as in (H).
(H) A diagram of Bmp4 gene region surrounding the transcription start site showing E-boxes and the deletion used in (G).
(I) Chromatin immunoprecipitation (ChIP) performed on cell lines stably transfected with Scx tagged with Xpress epitope (Scx) or empty vector (puro).
(J) Plasmid IP performed on cells cotransfected with the intact Bmp4 promoter (pGL3B4 full) or Bmp4 promoter with 3-nucleotide substitutions ablating the
E-boxes (pGL3B4 mut) and Scx-expressing vector.
In (I) and (E), qRT-PCR was performed with primers specific to the E-boxes region of the Bmp4 promoter (n = 3). Error bars represent the standard deviation
from the mean.
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increased transcription, we transiently cotransfectedC3H10T1/2
and HeLa cell lines with a construct that contained a 0.9 kb of
Bmp4 promoter region fused to luciferase cDNA (pGL3 BMP4
full) and Scx-expressing vector. These experiments revealed
approximately 3-fold induction of luciferase activity relative to
the control vector (Figure 4G; for C3H10T1/2 cells, data not
shown).
Next, we searched the mouse Bmp4 promoter for SCX
consensus binding sites (also referred to as E-box). We iden-
tified two putative binding sites in positions 242 (CACGTG)
and 230 (CAGGTG) upstream to the transcription initiation
site (Figure 4H); these consensus sequences were previously
shown to bind scleraxis (Lejard et al., 2007; Liu et al., 1997). In
order to examine whether these two E-boxes were necessary
for SCX induction ofBmp4 expression, wemade two constructs:
one with mutated E-boxes (pGL3 B4mut: CACGTG–CACAAA,
CAGGTG–CAGAAA) and another that contained a region down-866 Developmental Cell 17, 861–873, December 15, 2009 ª2009 Elsstream of the E-Boxes (pGL3 del1). We compared the ability of
SCX to induce luciferase activity in the mutated promoter and
in the intact promoter. As can be seen in Figure 4H, as well as
indicating a deletion of the Bmp4 promoter, the two mutations
of the E-boxes blocked the ability of SCX to induce luciferase
activity.
In order to demonstrate a direct binding of scleraxis protein
to the Bmp4 promoter, we performed a chromatin immunopre-
cipitation (ChIP) experiment. Chromatin was prepared from
C3H10T1/2 cells lysate stably expressing Scx tagged with
Xpress epitope. The lysate was incubated with either an anti-
Xpress-tag antibody or anti-GFP antibody (as control). qRT-
PCR analysis using specific primers to the E-boxes region of
Bmp4 promoter revealed binding of SCX to the indicated
promoter region (Figure 4I).
To further validate the specificity of the two identified E-box
sequences for SCX binding, we utilized a plasmid IP experiment.
To that end,HeLa cellswhere cotransfectedwithScx-expressingevier Inc.
Figure 5. BMP4 Mediates DT Initiation
(A) In situ hybridization of DT sagittal sections from E14.5 WT mice using anti-sense complementary RNA probes for Alk3.
(A0) Enlargement of the boxed area in (A) highlights the border between DT and tendon cells.
(B) Sagittal sections through the humerus of WT E14.5 embryo counterstained with anti-P-Smad 1/5/8 antibody (circle indicates DT area).
(C and G) Skeleton preparation and (D and H) histological sagittal sections through the humeri of E14.5 Prx1-Bmp4 and Scx-Bmp4 mutants lack the DT.
(E and I) In situ hybridization of DT sagittal sections from E14.5 mice, using anti-sense complementary RNA probes for Scx.
(F) Section of whole-mount b-gal staining of E14.5 Scx-Cre, R26R-lacZ limbs demonstrates b-galactosidase activity in the tendons. Enlargements of the boxed
areas highlight the insertion of tendons to (F0) the radius bone and to (F00) the DT.
(J–L) Examination of tendon differentiation in Scx-Bmp4 mutants.
(J and K) In situ hybridization of humerus sagittal sections from E14.5 mice, using anti-sense complementary RNA probes for Col1a1 and Tnmd mRNA.
(L) Sagittal sections from E14.5 control and Scx-Bmp4 mutants stained with anti-tenascin C (TNC) antibody.
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B4 full) or the Bmp4 promoter with the mutated E-boxes
(pGL3 B4mut). As can be seen in Figure 4J, qRT-PCR analysis
revealed that the mutations in the E-boxes completely ablated
the binding of SCX to the Bmp4 promoter. Therefore, we
conclude that scleraxis binds the Bmp4 promoter and regulates
its transcription.
Bmp4 Expression in Tendons Regulates DT Initiation
To establish that BMP4mediates signaling from tendons to carti-
lage in the regulation of bone ridge initiation, we wanted to
demonstrate that BMP signaling was activated in the initiating
DT and was required for its formation. To detect an activationDevelopmeof BMP signaling in chondrocytes of the forming DT, we exam-
ined the expression of Alk3, a type IA receptor for BMP4
(BmprIA) (Yamaji et al., 1994). In E14.5 control mice, Alk3 was
expressed within muscles and cartilage, but not in tendons
(Figure 5A). Next, we directly tested the activation of the BMP
pathway by examining the activation of Smad proteins, the
downstream mediators of the BMP signaling cascade (Shi and
Massague, 2003), using a specific antibody that detects the
phosphorylated form of Smad 1, 5, and 8 (P-Smad). P-Smad
1/5/8 staining in E14.5WT forelimbwas observed in DT chondro-
cytes (Figure 5B). Taken together, these results support the
notion that SCX-dependent expression of Bmp4 in tendons
activates BMP signaling in tuberosity-forming chondrocytes.ntal Cell 17, 861–873, December 15, 2009 ª2009 Elsevier Inc. 867
Figure 6. The Loss of Bmp4 in Tendons Has a Wide Effect on Bone Ridge Development throughout the Skeleton
Micro-CT analysis of 14 day old WT and Scx-Bmp4mice showing bone ridges located on the (A and A0) forelimbs, (B and B0) hindlimbs, and (C and C0) vertebrae.
(A) Green arrows indicate the ridge distal to the minor tubercle on the medial aspect of the humerus. Red arrows indicate the greater tubercle of the humerus.
Yellow arrows indicate the olecranon of the ulna. Blue circles indicate the medial epicondyle of the humerus. Blue arrows indicate lateral epicondyle of the
humerus. White arrows indicate the olecranon of the ulna. Purple arrows indicate the radial tuberosity, located on the radius.
(B) Green arrows indicate the lunate surface of the acetabulum, located on the pelvis. Red arrows indicate the greater trochanter of the femur. Yellow arrows
indicate the third trochanter of the femur. Blue arrows indicate the tibial crest.
(C) Pink circles indicate the accessory process on the lamina of the vertebra. White arrows indicate the spinous process of the vertebra.
Abbreviations: s, scapula; h, humerus; r, radius; u, ulna; p, pelvis; f, femur; t, tibia.
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tive for DT initiation, we blocked the expression of Bmp4 in limb
mesenchyme using the Prx1-Cre as a deleter (Prx1-Bmp4).
Examination of skeletal preparation and histological sections of
E14.5 Prx1-Bmp4 limbs revealed the lack of DT initiation (Figures
5C and 5D). To further demonstrate that this phenotype was
specifically related to Bmp4 abolishment in tendon cells, we
blocked the expression of Bmp4 in Scx-expressing cells using
the Scx-Cre as a deleter (Scx-Bmp4; the Scx-Cre mice will be
reportedelsewhere). To evaluate theeffectiveness andspecificity
of Scx-Cre as a deleter in tendon cells, we crossed the Scx-Cre868 Developmental Cell 17, 861–873, December 15, 2009 ª2009 Elsmice with R26R-lacZ reporter mice (Soriano, 1999). Examination
of Scx-Cre, R26R-lacZ heterozygous embryos at E14.5 revealed
lacZ expression in the forming tendons (Figure 5F).
Next, we examined skeletal preparations and histological
sections of limbs from E14.5 Scx-Bmp4 embryos and detected
no DT initiation (Figures 5G and 5H). To exclude the possibility
that tuberosity loss resulted from the lack of tendons in these
mutants’ limbs, or that Bmp4 expression was necessary for
the expression of Scx in these limbs, we examined histological
sections and the expression of Scx in limbs of Prx1-Bmp4 and
Scx-Bmp4 embryos. Scx expression was not affected in theevier Inc.
Figure 7. Our Model for Bone Ridge Formation by a Biphasic
Process
A scheme of the forelimb skeleton that illustrates the involvement of tendons
and muscles in bone ridge formation.
(A) Magnification of the circled area at the scheme above. We suggest a model
for the contribution of both tendons and muscles to bone ridge formation in
a biphasic process, as tendons regulate tuberosity initiation and muscles
control its subsequent growth. While we have begun to reveal the molecular
mechanism that underlies tendon regulation of bone ridge initiation, the mech-
anism whereby muscle contraction regulates bone ridge growth remains to be
uncovered.
(B)Magnification of the squared area in (A). Focusing on tendon-cartilage inter-
action in the initiation phase, we identify the bHLH transcription factor SCX as
a regulator ofBmp4 expression in tendon cells. Next, upon binding of BMP4 to
its receptor ALK3 in chondrocytes, a signaling cascade is activated leading,
eventually, to the initiation of a bone ridge.
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presumed attachment site to the humerus (see Figure S3B and
S3C available online); moreover, these tendons apparently
attached directly to the perichondrium instead of to the DT, as
in the control limbs. Further analysis of tendon integrity was
conducted on the Scx-Bmp4 embryos by examining the expres-
sion of Scx, collagen type I alpha 1 (Col1a1), tenomodulin
(Tnmd), and tenascin C (Tnc), markers of tendon differentiation.
The expression of Scx, Col1a1, Tnmd, and Tnc in mutants’
tendons (Figures 5J–5L) indicated normal differentiation.
Finally, to evaluate the contribution of Bmp4 expression in
tendons to bone ridge formation throughout the skeleton, we
examined the development of a wide variety of bone ridges in
2-week-old Scx-Bmp4 mice by micro-CT scanning. As can be
seen in Figure 6, the loss of Bmp4 in tendons led to aberrant
formation of numerous ridges in the axial and appendicular
skeleton; however, not all the ridges were affected.
These results strongly support our hypothesis that SCX regu-
lation of Bmp4 expression in tendons regulates bone ridge initi-
ation. Moreover, these results implicate BMP4 as a keymolecule
in the mechanism that mediates signaling from tendon cells to
chondrocytes at their attachment site.
DISCUSSION
Bone ridges are critical for the ability of the skeleton to cope
with the mechanical load applied by the musculature. In this
study, we show that tendon attachment to the skeleton regulates
bone ridge formation and identify SCX regulation of Bmp4 as the
underlying molecular mechanism. Moreover, we describe the
contribution of muscular activity to the regulation of the bone
ridge size. This study examines the development of the skeleton
as part of the musculoskeletal system, demonstrating the cen-
trality of cartilage-tendon interaction for secondary patterning
of the skeleton.
DT as a Miniature Growth Plate
Bone ridges are poorly studied. Notwithstanding, several studies
have been performed on postnatal skeletons, focusing on the
connective tissue interface between skeleton and tendons,
which is classified as either fibrous or fibrocartilaginous accord-
ing to the tissue that occupies the attachment site (Benjamin
et al., 2002, 2006).
We show that the DT is formed through endochondral ossifica-
tion (Figure 1). Hence, this lateral outgrowth from the humerus
does not represent a new cellular mechanism for the generation
of skeletal tissue, but rather a deployment of the cellular and
molecular cascade of endochondral bone formation along
a secondary axis. Considering the large variability of bone ridge
morphology, it is yet to be determined whether they all develop
by the same process.
In contrast to primary growth plates, the formation of the
growth plate of the DT is dependent on tendons and muscles
(Figures 2A–2D, and 3C; Figures S1A–S1C). This difference in
the mode of regulation suggests that during development, the
skeleton is regulated by at least two different programs. The first
is the intrinsic genetic program that largely regulates the initial
steps in bone formation. Later on, when the skeleton begins to
interact with tendons and muscles, signals from these tissuesDevelopmecontribute to its secondary patterning. We speculate that this
extrinsic regulation ensures the proper assembly of the muscu-
loskeletal system and its adaptation to the changing require-
ments of the organism.
Our observation that similarly to long bones, the DT forms by
a growth plate highlights the evolutionary advantage of this
cellular mechanism in bone formation. Yet, the difference in the
mode of regulation between these distinct growth plates illus-
trates its modularity.
The Molecular Mechanism Underlying Tendon
Regulation of DT Formation
The initiation of the DT at E13.5 (Figures 1D and 1E) is synchro-
nized with the differentiation of tendons and muscles at theirntal Cell 17, 861–873, December 15, 2009 ª2009 Elsevier Inc. 869
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et al., 2007). This concurrence allows for a regulatory crosstalk
among the various musculoskeletal tissues. Indeed, using the
Prx1-Tgf-bRII mutant as a model for ‘‘tendon-less’’ mice (Pryce
et al., 2009), we demonstrate that the initiation of bone ridges
such as the DT and the third trochanter of the femur does not
occur in the absence of tendons (Figures 3A–3C; Figure S1C).
This clearly implies the centrality of tendons in bone ridge
development.
In Prx1-Tgf-bRII embryos, TGFb signaling was disrupted
throughout the limb mesenchyme. The failure in DT growth in
these mutants could also be attributed to the disruption of
TGFb signaling in chondrogenic tissues. However, the DT was
not affected when Tgf-bRII expression was targeted in chondro-
cytes, using the Col2a1-Cre deleter (Baffi et al., 2004).
The concept that a crosstalk between a tendon and the
tissue to which it attaches is necessary for the development of
the musculoskeletal system was previously demonstrated in
Drosophila (Volk, 1999). In the Drosophila embryo, tendon cells
direct myotube migration and final patterning, while muscles
are essential for the maintenance of the fate of tendon cells.
Another example for the active role that tendons play during
the assembly of the musculoskeletal system was found in inci-
dences of human congenital defects, in which tendons were
attached to structures other than their normal ‘‘targets’’ (Graham
et al., 1982). These observations suggest that tendons may be
actively involved in determining their attachment site.
Our genetic and molecular data clearly demonstrate that
Bmp4 expression in tendons is necessary for the initiation of
bone ridges such as the DT (Figures 5C and 5G). Consistent
with our findings, the abrogation of Bmpr1a expression in limb
mesenchyme led to the formation of a humerus devoid of a tuber-
osity (Ovchinnikov et al., 2006). Our finding that some ridges and
tuberosities were formed in mice in which Bmp4 expression
was blocked in tendon cells suggests that other signaling
molecules may play a role in this process. Support for this
supposition comes from a previous study in mice with a domi-
nant-negative Bmp5 mutation that suggested the involvement
of BMP signaling in bone ridge response to mechanical stimula-
tion (Ho et al., 2008). Given that BMP4 regulates DT initiation, it is
possible that various BMPs are involved in the regulation of bone
ridge development at different stages.
Relatively little is known about the molecular players that
mediate the regulatory interactions among the tissues of the
musculoskeletal system during its assembly (Tozer and Duprez,
2005). Previous studies have shown in somites that FGFs from
the myotome induce adjacent sclerotomal cells to become
tendon cells (Brent et al., 2003; Brent and Tabin, 2004). Other
molecules that emanate from muscles and cartilage to regulate
tendon formation are the TGFbs (Pryce et al., 2009). Comple-
menting these studies, we show that SCX regulation of Bmp4
in tendons serves as the reciprocal signal by which tendons
regulate cartilage at the attachment site.
Another open question raised by this study regards the mech-
anism that specifies a field of cells in the developing humerus,
which upon receiving the BMP4 signal gives rise to the formation
of the DT. Since the expression of BmprIA was not restricted to
tuberosity-forming chondrocytes and Bmp4 expression was
restricted to tendon insertion sites, it is possible that the diffusion870 Developmental Cell 17, 861–873, December 15, 2009 ª2009 Elscapability of BMP4 is the factor that determines and restricts this
field. Another hypothesis is the existence of bone ridge progen-
itor cells that respond to the signal emanating from the tendons.
To validate this hypothesis, it is necessary to identify molecular
markers associated with these progenitor cells, as well as the
signal that activates them.
The Assembly of the Musculoskeletal System Dictates
a Biphasic Process for DT Formation
The influence of stress and strain on the bone was well estab-
lished in the early days of bone research (Koch, 1917; Wolff,
1892; Roux, 1881). Studies by Pottorf (1916) and Howell (1917)
clearly demonstrated that the effect of mechanical load created
by muscle contraction was much more dramatic than the effect
of weight pressure. A role for muscle-induced mechanical load
in the formation of bone ridges was first suggested following
bone transplantation studies (Hamburger, 1938, 1939, 1940). In
these experiments, the humerus was transplanted to the umbil-
ical cord leading to a reduction in the size of the DT, thus
indicating the need for a proper musculoskeletal junction to
ensure a normal bone ridge development. Studies on immobi-
lized chick embryos (Hall and Herring, 1990; Hosseini and
Hogg, 1991) and mice that lacked either skeletal muscles or
muscle contractility further indicated the contribution of muscle
contraction to tuberosity formation (Pai, 1965a; Rot-Nikcevic
et al., 2006; Tremblay et al., 1998). Interestingly, human patients
with a contracture of the deltoid muscle exhibit an enlargement
of the DT (Ogawa et al., 1999).
Based on our developmental analysis, we support a role for
the musculature in bone ridge formation. However, we demon-
strate that the formation of the DT and other bone ridges, such
as the third trochanter, is initiated in the absence of contracting
muscles (Figures 2C and 2D; Figure S1A). Furthermore, chon-
drocytes in the DT of these mutants even differentiate to
hypertrophy (Figures 2E–2I). It is, in fact, the subsequent
growth phase, which unfolds via chondrocyte proliferation, that
depends onmuscle contraction, as in its absence the DT ceased
to develop and was ultimately engulfed by the growing humerus
(Figure S2).
These observations led us to conclude that bone ridges are
formed through a two-phase process. During the initiation
phase, tendons are sufficient and muscles are dispensable,
whereas tuberosity growth during the subsequent phase is
muscle-dependent. The reason for the selection of such a
biphasic developmental process may lie in the need of the
attachment site to supply sufficient initial anchoring capabilities.
Thus, the regulation of bone ridge initiation is predetermined.
Once a substantial size is achieved, the regulation can be then
coupled to muscular activity, allowing for a tight, dynamic coor-
dination between physical strain on one hand, and anchoring
and force dissipation capabilities on the other.
The existence of tendon cells at the attachment site, without
respect to the formation of a functioning musculature (Figures
3H and 3J), was also reported in Myf5/;MyoD/ mice (Brent
et al., 2005) and in chick embryos (Kardon, 1998). However, later
in development, tendon formation requires the presence of
muscles (Bonnin et al., 2005; Brent et al., 2005; Edom-Vovard
et al., 2002; Kardon, 1998; Kieny and Chevallier, 1979; Schweit-
zer et al., 2001). In view of these observations, the extent ofevier Inc.
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phase remains an open question. It is yet to be determined
whether tendon cells, in response to muscle contraction,
produce a signal that induces growth in the tuberosity cells, or
whether tendinous tissue acts passively by transmitting to the
tuberosity forming cells the force applied by the musculature,
which regulates their proliferation.
This study describes the interaction that occurs during
embryogenesis among the three components of the musculo-
skeletal system at their intersection point, the bone ridge. We
reveal the regulatory role ofmuscles and tendons in cartilaginous
bone ridge formation and identify SCX regulation of Bmp4 as the
molecular mechanism that underlies the induction of tuberosity
development by tendons (Figure 7). These findings provide
a new perspective on the regulation of skeletogenesis in the
context of the musculoskeletal system and shed light on the
mechanism that underlies the assembly of this system.
EXPERIMENTAL PROCEDURES
Animals
Heterozygous Spd mice (Dickie, 1964) and Scx/ mice (Murchison et al.,
2007) have been previously described. Mice heterozygous for the mutation
muscular dysgenesis (mdg) (Pai, 1965a) were kindly provided byG. Kern, Inns-
bruck, Austria. The generation of floxed-Prx1-Tgf-bRII (Chytil et al., 2002),
Prx1-Cre (Logan et al., 2002), and Bmp4 conditional allele (Liu et al., 2004;
Selever et al., 2004) have been described previously. The generation of Scx-
Cre transgenic mice will be described elsewhere by R. Schweitzer and
R.L. Johnson. To create Spd, mdg, and Scx/ mutant mice, animals hetero-
zygous for the mutation were crossed; as a control we used heterozygous
Spd, mdg, and Scx embryos.
To create Prx1-Tgf-bRII and Prx1-Bmp4 mutant mice, floxed-Tgf-bRII and
floxed-Bmp4mice were mated to Prx1-Tgf-bRII and Prx1-Bmp4. As a control,
we used embryos heterozygous for floxed-Tgf-bRII or floxed-Bmp4 and Prx1-
Cre alleles. To create Scx-Bmp4 conditional mutant mice, floxed-Bmp4 mice
were mated to Scx-Bmp4mice; as a control, we used embryos heterozygous
for floxed-Bmp4 and Scx-Cre alleles.
In all timed pregnancies, plug date was defined as E0.5. For harvesting
of embryos, timed-pregnant females were sacrificed by CO2 intoxication.
The gravid uterus was dissected out and suspended in a bath of cold
phosphate-buffered saline (PBS), and the embryos were harvested after
amnionectomy and removal of the placenta. Tail genomic DNA was used for
genotyping.
Skeletal Preparations
Cartilage and bones in whole mouse embryos were visualized after staining
with Alcian blue and Alizarin red S (Sigma) and clarification of soft tissue
with KOH (McLeod, 1980).
Micro-CT Analysis
Three-dimensional images were obtained from the left hindlimb, forelimb, and
lumbar vertebrae of Scx-Bmp4 mice using microcomputed tomography (GE
Healthcare, London, Ontario, Canada). Scans were taken at 16-micron
isotropic resolution and images were reconstructed and thresholded to distin-
guish bone voxels with MicroView software version 5.2.2 (GE Healthcare). One
threshold was chosen for all specimens.
Histological Analysis and In Situ Hybridization
For histology and in situ hybridization, embryos were sacrificed at various
ages, dissected, and fixed in 4% paraformaldehyde (PFA)/PBS at 4C over-
night. After fixation, tissues were dehydrated to 100% ethanol and embedded
in paraffin. The embedded tissues were cut to generate 7 mm thick sections
and mounted onto slides.
Section in situ hybridizations were performed as described previously (Mur-
taugh et al., 1999; Riddle et al., 1993). All probes are available by request.DevelopmeHematoxylin and eosin (H&E) staining was performed following standard
protocols. Double fluorescent in situ hybridizations on paraffin sections were
performed using biotin- and DIG-labeled probes. After hybridization slides
were washed, quenched, and blocked. Probes were detected by incubation
with strepavidine-HRP (Perkin Elmer, diluted 1 in 1500) and anti-DIG-HRP
(Roche, dilute 1 in 50), followed by Cy3- or Cy2-tyramide labeled fluorescent
dyes (according to the instructions of the TSA Plus Fluorescent Systems Kit,
Perkin Elmer).
BrdU Assay
Pregnant mice were injected intraperitoneally with 100 mg/kg body weight of
BrdU labeling reagent (Sigma) and sacrificed 2 hr later. Embryo tissues were
fixed in 4% PFA at 4C overnight, processed, and embedded in paraffin.
Sections of the limb were cut at 7 mm, dewaxed, and rehydrated. Antigen
retrieval was performed by microwaving the sections in 0.01 M sodium citrate
buffer (pH 6.0). Sections were then washed with 1% bovine serum albumin/
PBS-Triton wash buffer (PBS +0.5% Triton). In order to block nonspecific
binding of immunoglobulin, sections were incubated with 1% bovine serum
albumin + 5% goat serum for 60 min at room temperature. After blockage,
sections were incubated with the primary antibody G3G4 anti-BrdU (1:100;
DSHB, The University of Iowa) overnight at 4C. Then, sections were washed
in PBS and incubated with the secondary fluorescent antibody, Alexa 568
(1:100; Invitrogene). To quantify the rate of cell proliferation, serial images
of the same humerus were collected and BrdU-positive chondrocytes (red)
and -negative chondrocytes (gray) in the DT tip region were counted. At least
three sections were counted for each of four control andmdgmutant littermate
embryos at E14.5 and E16.5. Statistical significance was determined by
Student’s t test.
Whole-Mount b-Galactosidase Staining
Embryos were fixed for 1 hr in 4% PFA at 4C, washed three times in rinse
buffer containing 0.01% deoxycholate, 0.02% NP-40, 2 mM MgCl2, and
5 mM EGTA at room temperature, and stained for 3 hr at 37C in rinse buffer
supplemented with 1 mg/ml X-gal, 5 mM K3 Fe(CN)6, and 5 mM K4 Fe(CN)6.
For histological examination, stained whole-mount limbs were fixed in 4%
PFA overnight, dehydrated, embedded in paraffin, and used to generate
7 mm thick sections, which were collected on Fisherbrand Superfrost Plus
slides, dehydrated, and cleared in xylene.
Immunofluorescence
For immunofluorescence, embryo limbs were embedded in OCT (Tissue-
Tek) after 2–6 hr fixation in 4% PFA and 10 mm cryostat sections were
made. Cryosections were postfixed for 30 min in 4% PFA and permeabilized
with 0.2% Triton/PBS. In order to block nonspecific binding of immunoglob-
ulin, sections were incubated with 7% goat serum. Following blockage,
cryosections were incubated overnight at 4C with primary antibodies: anti-
collagen II (1:100; DSHB, University of Iowa), anti-tenascin C (1:100; Harold
Erickson, Duke University). Then, sections were washed in PBS and incubated
with secondary fluorescent antibodies Cy3 (1:100; Jackson Laboratories). The
signal of the transgenic tendon reporter ScxGFP was captured directly from
alternating cryosections. Hoechst was used for counterstaining.
Vectors
Express epitope-taggedScx cDNA (a kind gift from J. Rossert) was cloned into
pEF-IRES-puro vector. A 0.8 kb fragment of Bmp4 promoter (a kind gift from
C.G. Kim) (Kang et al., 2004) was cloned into pGL3 vector upstream of lucif-
erase ORF. Mutations of E-boxes in positions 242 and 230 in the Bmp4
promoter were produced by PCR using the following primers: TGCTTTCTAG
TACCTCTTGCACAAAGTCCCCAGAAAAGCCCCGGCTGCTTCCCGAG and
its anti-sense (mutated regions underlined).
Tissue Culture, Transfections, Luciferase Assay, and Stable Lines
Preparation
C3H10T1/2 cells (a kind gift from D. Zipori) were kept in culture according to
ATCC recommendations. For Bmp4 promoter experiments, 1 mg of pGL3
Bmp4 was cotransfected in 6-well plates with 2 mg of pEF-Sxc-IRES-puro or
with empty vector to HeLa or C3H10T1/2 cells using JetPei reagent. Each
well was also cotransfected with 200 ng of renilla-expressing plasmid.ntal Cell 17, 861–873, December 15, 2009 ª2009 Elsevier Inc. 871
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were normalized to Renilla activity. For transient Scx overexpression in
C3H10T1/2 cells, they were transfected using Lipofectamine 2000 reagent
(Invitrogen) according to the manufacturer’s instructions and cells were
harvested after 48 hr. In order to obtain a cell line stably overexpressing
Scx, C3H10T1/2 cells were transfected with pEF-Scx-IRES-puro construct
or with empty vector and selected with 3 mg/ml of puromycin (Sigma). The
presence of SCX in the resulting lines was verified by western blot with anti-
express epitope antibody (Invitrogen). All experiments described above were
performed at least three times.
Quantitative RT-PCR (qRT-PCR)
In each experiment, RNAwas purified using RNAeasy kit (QIAGEN). cDNAwas
synthesized from 1 mg of RNA with SuperScript II First-Strand kit (Invitrogen).
qRT-PCR was performed using SYBR Green (Roche). Values were calcu-
lated with the second derivative method and normalized to actin expression.
For PCR, the following primers were used:
Bmp4: sense, GTGACACGGTGGGAAACTTTCGAT, anti-sense, CACCTCA
ATGGCCAGCCCATAAT;
Scx: sense, CAGCCCAAACAGATCTGCACCTT, anti-sense, TTCGAATCGC
CGTCTTTCTGTCA.
Chromatin Immunoprecipitation
Chromatin preparation and ChIP were performed as described previously
(Amarilio et al., 2007). For IP, 1 mg of either mouse anti-Xpress antibody (Invi-
trogen) or anti-GFP antibody (Abcam) was added to sonicated chromatin
corresponding to 1 million cells. Purified DNA from immunoprecipitates, as
well as of the input material, was analyzed by qRT-PCR using primers specific
to the region of the E-boxes: B4 sense, AAGCCCAGACTCCCATGGGTATTT;
B4 anti-sense, GGAAGATTGCACAGCTCCCCA. As a control we used primers
specific to the region of pGL3 plasmid 2.5 kb away from the cloned promoter:
pGL3 sense, CAGGGGATAACGCAGGAAAGAACA; pGL3 anti-sense, AAAG
GCGGACAGGTATCCGGTAA. Results were normalized and presented as
percentage of input DNA.
Formaldehyde Crosslinked Immunoprecipitation
For immunoprecipitation of exogenousmouseBmp4 promoter, 70%confluent
HeLa cells in 14 cm dishes were cotransfected with pEF-Scx-IRES-Puro and
pGL3-Bmp4 WT promoter or promoter with mutated E-boxes. For analysis
of the endogenous promoter, C3H10T1/2 cells stably transfected with
pEF-Xpress-mScx-IRES-Puro or with empty vector were used. In all the
experiments cells were crosslinked with 1% formaldehyde for 15 min and
trypsinyzed.
SUPPLEMENTAL DATA
Supplemental Data include three figures and can be found with this article
online at http://www.cell.com/developmental-cell/supplemental/S1534-
5807(09)00432-8.
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